Related Experiment Videos
Transamniotic fetal feeding. III. The effect of nutrient infusion on fetal growth retardation
Insights
Transamniotic fetal feeding (TAFF) did not improve growth in a rabbit model of intrauterine growth retardation (IUGR). Nutrient infusions, especially lipids, showed no benefit and could be harmful, suggesting oxygen, not just nutrients, limits growth.
Area of Science:
- Perinatal medicine
- Fetal development
- Neonatology
Background:
- Small-for-gestational age (SGA) infants, often due to intrauterine growth retardation (IUGR), face significant health risks.
- IUGR typically stems from insufficient maternal-fetal nutrient or oxygen transfer.
- Transamniotic fetal feeding (TAFF) is a proposed intervention for IUGR, involving fetal swallowing of infused amniotic fluid nutrients.
Purpose of the Study:
- To evaluate the efficacy of transamniotic fetal feeding (TAFF) in treating fetal growth retardation (IUGR).
- To investigate the impact of specific nutrient infusions on fetal growth in a rabbit IUGR model.
Main Methods:
- Utilized a rabbit model of IUGR based on fetal position within the uterine horn.
- Administered infusions of dextrose, a dextrose-amino acid mixture, or lipid emulsion into the amniotic fluid.
- Compared fetal growth and health outcomes between treated and control groups.
Main Results:
- Infusion of dextrose, dextrose-amino acid mixture, or lipid did not reverse or improve fetal IUGR compared to controls.
- Lipid emulsion infusion led to chronic lipid aspiration and exacerbated growth retardation.
- The study found no evidence supporting TAFF for IUGR treatment.
Conclusions:
- Transamniotic fetal feeding (TAFF) is not an effective treatment for intrauterine growth retardation (IUGR) based on this rabbit model.
- Oxygen availability, rather than substrate deficiency, may be the primary growth-limiting factor in IUGR.
- Amniotic fluid lipid infusions can be detrimental to fetal development, causing aspiration and further growth restriction.
Abstract:
The small-for-gestational age (SGA) infant resulting from intrauterine growth retardation (IUGR) is at high risk for perinatal complications and chronic morbidity. Most IUGR is the result of inadequate transfer of nutrients and/or oxygen from mother to fetus. Transamniotic fetal feeding (TAFF) has been proposed as a method of treating IUGR in which nutrients infused into the amniotic fluid would be swallowed, absorbed, and used by the growth retarded fetus. To study the efficacy of TAFF in the treatment of IUGR, we have previously described a rabbit model for TAFF that takes advantage of the relationship between "natural runting" (IUGR) and position on the uterine horn. We report on a controlled study of the effects of specific nutrient infusion on fetal growth retardation in this model. The infusion of dextrose, a dextrose-amino acid mixture, or lipid did not reverse or ameliorate fetal IUGR compared with controls. In addition, the infusion of lipid emulsion resulted in chronic lipid aspiration and further growth retardation. This work does not support the use of TAFF as a prenatal treatment for IUGR and suggests that oxygen may be the growth-limiting factor in most substrate deficiency IUGR. In addition, the infusion of solutions containing lipid may be harmful to the developing fetus.